As an MD with 100,000 shares I can tell you that this is excellent news.
Pain, sleep and fatigue are very common symptoms.
Many pain pills are addictive or cause sedation, GI upset, heart, liver or kidney problems.
Most sleeping pills are addictive or cause daytime sleepiness.
Most drugs for fatigue cause insomnia.
If we can help these 3 symptoms with minimal side effects, sales will explode.
There will be ups and downs as 2022 is mentioned for drug approval and today’s investors are impatient.
I would expect that larger pharm companies may want to buy out our little gem.
Thank you Seth. Great job.